Executive Summary
Xeriant Inc reported a QQ4 2024 period with no disclosed revenue and a pronounced loss profile consistent with a development-stage aerospace tech company. Gross loss of $13,573 was driven by cost of revenue matching the minimal disclosed revenue, followed by substantial operating expenses that culminated in an operating loss of $894,111 and a net loss of $1,160,854 for the quarter. EBITDA stood at a negative $851,911, reflecting heavy R&D and G&A burn rather than stabilized operating leverage. The quarterly cash flow picture underscored liquidity constraints: operating cash flow was negative $370,451, and free cash flow was negative $370,451, while cash and equivalents at period end were $653,117. On the balance sheet, liabilities vastly exceeded assets and equity, with total liabilities of $9.33 million against assets of about $0.71 million and negative stockholders’ equity of $5.75 million, signaling meaningful solvency risk absent new financing or revenue generation. Management commentary for QQ4 2024 is not available in the provided transcript set, limiting direct quotes on strategy and execution. Overall, the quarter reinforces a high-risk, early-stage aerospace tech investment profile where the potential upside hinges on monetization of Halo/VTOL concepts, licensing deals, strategic partnerships, and access to additional equity or debt capital.”,
Key Performance Indicators
QoQ: -153.32% | YoY:-129.62%
QoQ: -208.47% | YoY:-97.66%
QoQ: -225.00% | YoY:-73.33%
Key Insights
Revenue: Not disclosed for QQ4 2024 (revenue field is null). Gross Profit: −$13,573 for QQ4 2024; Gross Margin: N/A due to missing revenue figure; YoY Gross Profit change: −11.25%; QoQ Gross Profit change: −2.72%. Operating Income: −$894,111 for QQ4 2024; YoY Operating Income change: −129.62%; QoQ change: −153.32%. Net Income: −$1,160,854 for QQ4 2024; YoY Net Income change: −97.66%; QoQ change: −208.47%. EPS: −$0.00260 for QQ4 2024; YoY EPS change: −73.33%; QoQ change: −...
Financial Highlights
Revenue: Not disclosed for QQ4 2024 (revenue field is null). Gross Profit: −$13,573 for QQ4 2024; Gross Margin: N/A due to missing revenue figure; YoY Gross Profit change: −11.25%; QoQ Gross Profit change: −2.72%. Operating Income: −$894,111 for QQ4 2024; YoY Operating Income change: −129.62%; QoQ change: −153.32%. Net Income: −$1,160,854 for QQ4 2024; YoY Net Income change: −97.66%; QoQ change: −208.47%. EPS: −$0.00260 for QQ4 2024; YoY EPS change: −73.33%; QoQ change: −225.00%. Cash flow from operations: −$370,451; Free cash flow: −$370,451; Net change in cash: $279,549; Cash at end of period: $653,117. Balance sheet health indicators show current ratio of 0.0712 and quick ratio of 0.0712, signaling severe near-term liquidity constraints. Total debt: $8,018,726; Net debt: $7,365,609; Total assets: $713,005; Total liabilities: $9,325,459; Total stockholders’ equity: −$5,752,513. Weighted average shares: 443,262,234. Note: Revenue and some balance sheet figures appear inconsistent with the scale of liabilities versus assets (likely indicative of data integrity issues in the provided extract).
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Gross Profit |
-13.57K |
-11.25% |
-2.72% |
| Operating Income |
-894.11K |
-129.62% |
-153.32% |
| Net Income |
-1.16M |
-97.66% |
-208.47% |
| EPS |
0.00 |
-73.33% |
-225.00% |
Key Financial Ratios
operatingCashFlowPerShare
$-0
Management Commentary
No earnings call transcript or management quotes were provided for QQ4 2024. The transcriptHighlights section therefore does not contain direct management quotes. Implication: without verbatim management commentary, the analysis relies on disclosed P&L, cash flow, and balance sheet data. If a call exists, expected themes would likely include discussions of Halo/VTO L development, capital strategy, and any potential strategic partnerships or licensing opportunities.
Forward Guidance
There is no explicit forward guidance attached to the QQ4 2024 data in the supplied material. The absence of guidance heightens reliance on management commentary once disclosed. In this context, the near-term path appears contingent on: (i) securing additional funding (equity injection or debt facilities) to bridge liquidity and support ongoing R&D; (ii) monetization opportunities related to Halo VTOL concepts, hybrid-electric propulsion, and other aerospace technologies; (iii) securing customers, partnerships, or government/defense program awards that can translate IP into revenue. Given the current balance sheet and cash burn, achievability of any forward targets would plausibly depend on favorable financing terms and credible monetization milestones within 12–24 months. Investors should monitor: (a) any capital-raising announcements, (b) licensing or collaboration deals, (c) updates on Halo drone program development, and (d) program progress with potential defense customers that could unlock grant or contract funding.